General Information of the Compound
Compound ID
CP0448441
Compound Name
N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)benzamide
    Show/Hide
Structure
Formula
C18H12ClN3O
Molecular Weight
321.767
Canonical SMILES
Clc1cc(NC(=O)c2ccccc2)c2[nH]c3cnccc3c2c1
    Show/Hide
InChI
InChI=1S/C18H12ClN3O/c19-12-8-14-13-6-7-20-10-16(13)21-17(14)15(9-12)22-18(23)11-4-2-1-3-5-11/h1-10,21H,(H,22,23)
    Show/Hide
InChIKey
HSOCWLKMVJTAGZ-UHFFFAOYSA-N
Physicochemical Property
logP
4.6218
Rotatable Bonds
2
Heavy Atom Count
23
Polar Areas
57.78
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 21362674
ChEMBL ID
CHEMBL78862
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01239, Inhibitor of nuclear factor kappa-B kinase subunit alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS